[Congressional Bills 107th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2629 Introduced in House (IH)]







107th CONGRESS
  1st Session
                                H. R. 2629

    To amend the Public Health Service Act to provide for research, 
        information, and education with respect to blood cancer.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

 Mr. Crane (for himself, Mrs. Roukema, Mr. Snyder, Mr. Ferguson, Mrs. 
   McCarthy of New York, Mr. McGovern, Mrs. Morella, Ms. Harman, Mr. 
Greenwood, Mr. Shimkus, Mr. Hall of Ohio, Mr. Rush, and Ms. Slaughter) 
 introduced the following bill; which was referred to the Committee on 
                          Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
    To amend the Public Health Service Act to provide for research, 
        information, and education with respect to blood cancer.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Hematological Cancer Research 
Investment and Education Act of 2001''.

SEC. 2. FINDINGS.

    Congress finds that:
            (1) An estimated 109,500 people in the United States will 
        be diagnosed with leukemia, lymphoma, and multiple myeloma in 
        2001.
            (2) New cases of the blood cancers described in paragraph 
        (1) account for 8.6 percent of new cancer cases.
            (3) Those devastating blood cancers will cause the deaths 
        of an estimated 60,300 persons in the United States in 2001. 
        Every 9 minutes, a person in the United States dies from 
        leukemia, lymphoma, or multiple myeloma.
            (4) While less than 5 percent of Federal funds for cancer 
        research are spent on those blood cancers, those blood cancers 
        cause 11 percent of all cancer deaths in the United States.
            (5) Increased Federal support of research into leukemia, 
        lymphoma, and multiple myeloma has resulted and will continue 
        to result in significant advances in the treatment, and 
        ultimately the cure, of those blood cancers as well as other 
        cancers.

SEC. 3. RESEARCH, INFORMATION, AND EDUCATION WITH RESPECT TO BLOOD 
              CANCER.

    Part B of title IV of the Public Health Service Act (42 U.S.C. 284 
et seq.) is amended by adding at the end the following:

``SEC. 409I. RESEARCH, INFORMATION, AND EDUCATION WITH RESPECT TO BLOOD 
              CANCER.

    ``(a) Research.--
            ``(1) In general.--The Director of NIH shall expand, 
        intensify, and coordinate programs for the conduct and support 
        of research with respect to blood cancer, and particularly with 
        respect to leukemia, lymphoma, and multiple myeloma.
            ``(2) Administration.--The Director of NIH shall carry out 
        this subsection through the Director of the National Cancer 
        Institute and in collaboration with any other agencies that the 
        Director determines to be appropriate.
            ``(3) Authorization of appropriations.--For the purpose of 
        carrying out this subsection, there is authorized to be 
        appropriated $250,000,000 for fiscal year 2002 and each 
        subsequent fiscal year. Such authorizations of appropriations 
        are in addition to other authorizations of appropriations that 
        are available for such purpose.
    ``(b) Joe Moakley Cancer Education Program.--
            ``(1) In general.--The Director of the Centers for Disease 
        Control and Prevention, in collaboration with the Director of 
        NIH, shall establish and carry out a program to provide 
        information and education for patients and the general public 
        with respect to blood cancer, and particularly with respect to 
        the treatment of leukemia, lymphoma, and multiple myeloma.
            ``(2) Administration.--The Director of the Centers for 
        Disease Control and Prevention shall carry out this subsection 
        in collaboration with private health organizations that have 
        national education and patient assistance programs on blood-
        related cancers.
            ``(3) Authorization of appropriations.--For the purpose of 
        carrying out this subsection, there is authorized to be 
        appropriated $25,000,000 for fiscal year 2002 and each 
        subsequent fiscal year. Such authorizations of appropriations 
        are in addition to other authorizations of appropriations that 
        are available for such purpose.''.
                                 <all>